Efficacy and limitations of 68-gallium DOTATATE PET/CT for neuroendocrine tumors: clinical experience following FDA approval. (March 2018)

Record Type:: Journal Article
Title:: Efficacy and limitations of 68-gallium DOTATATE PET/CT for neuroendocrine tumors: clinical experience following FDA approval. (March 2018)
Main Title:: Efficacy and limitations of 68-gallium DOTATATE PET/CT for neuroendocrine tumors: clinical experience following FDA approval
Authors:: Griffith, R.W.
McDonald, E.
Emmonds, L.
Gerhold, J.
Cohn, A.L.
Liu, E.
Abstract:
Is Part Of:: HPB. Volume 20(2018)Supplement 1
Journal:: HPB
Issue:: Volume 20(2018)Supplement 1
Issue Display:: Volume 20, Issue 1 (2018)
Year:: 2018
Volume:: 20
Issue:: 1
Issue Sort Value:: 2018-0020-0001-0000
Page Start:: S91
Page End:: S92
Publication Date:: 2018-03
Subjects:: Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:: https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1016/j.hpb.2018.02.344 ↗
Languages:: English
ISSNs:: 1365-182X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 10793.xml